Literature DB >> 4033662

Rabbit-mouse hybridomas secreting intact rabbit immunoglobulin.

M C Kuo, J A Sogn, E E Max, T J Kindt.   

Abstract

Rabbit-mouse hybridomas offer the potential for production of monoclonal rabbit antibodies by immortal cell lines. In previous studies, it was possible to produce and stabilize rabbit-mouse hybrid cells secreting either a rabbit heavy or light chain. These have been useful for structural characterization of the individual rabbit immunoglobulin polypeptides and for isolation of large amounts of immunoglobulin mRNA for molecular studies. For some studies, however, it would be useful to have intact rabbit immunoglobulin molecules comparable to the myeloma proteins available in the human and mouse. The availability of rapid, sensitive and specific assays for rabbit heavy and light chains and allotypes located on specific chains has now permitted the early identification of clones secreting intact rabbit immunoglobulin. Vigorous cloning efforts have resulted in isolation and partial stabilization of three such clones. The first, H105, secretes a product with a kappa light chain bearing the b6 allotype and a mu-chain bearing the a1 allotype. Biochemical and serologic analyses of the product show that it is secreted as a fully assembled IgM pentamer and that the rabbit heavy and light chains are covalently associated. No rabbit J-chain gene was detected in H105 by Southern blot analysis. The second hydridoma, H134, secretes a product with a mol. wt of 150 K, consisting of a b4 light chain and an a1 heavy chain. The third, H171, secretes an alb4 IgG with antibody specificity for group C streptococcal carbohydrate. An additional rabbit-mouse hybridoma, H89, have been produced which secretes a rabbit heavy chain lacking group a allotypic activity. The rabbit heavy chain, which is associated with a mouse light chain, has an N-terminal amino acid sequence identical to a2-positive molecules although thorough serologic analysis revealed no group a allotypic activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033662     DOI: 10.1016/0161-5890(85)90119-1

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas.

Authors:  Sara Alexandra Vinhas Ricardo; Fernanda Milanezi; Sílvia Teresa Carvalho; Dina Raquel Aguilera Leitão; Fernando Carlos Lander Schmitt
Journal:  J Clin Pathol       Date:  2006-12-08       Impact factor: 3.411

Review 2.  The production and application of non-rodent monoclonal antibodies in veterinary science.

Authors:  D J Groves; E M Tucker
Journal:  Vet Immunol Immunopathol       Date:  1989-11-30       Impact factor: 2.046

3.  Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.

Authors:  H Spieker-Polet; P Sethupathi; P C Yam; K L Knight
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  Conditioned medium from gerbil--mouse T cell heterohybridomas improved antibody secretion.

Authors:  Takao Ukaji; Masako Hashimoto; Osamu Kai
Journal:  Exp Anim       Date:  2015-02-10

Review 5.  Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors:  Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal:  Int Immunopharmacol       Date:  2020-05-27       Impact factor: 4.932

6.  A novel rabbit immunospot array assay on a chip allows for the rapid generation of rabbit monoclonal antibodies with high affinity.

Authors:  Tatsuhiko Ozawa; Xiuhong Piao; Eiji Kobayashi; Yue Zhou; Hiroaki Sakurai; Tsugunobu Andoh; Aishun Jin; Hiroyuki Kishi; Atsushi Muraguchi
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

7.  Optimization of culture conditions for feline x murine heterohybridomas.

Authors:  E Leidinger; E Kramberger-Kaplan; M Gemeiner
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1993-10       Impact factor: 2.268

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.